Bluesight, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bluesight, Inc. - overview
Established
2011
Location
Alexandria, VA, US
Primary Industry
Healthcare IT
About
Based in the US, Bluesight, Inc. operates as a technology company that delivers innovative solutions aimed at optimizing hospital and pharmacy operations through automation and integrated data management. Founded in 2011 and headquartered in Alexandria, US, Bluesight, Inc. specializes in enhancing healthcare operations.
The company was co-founded by Kevin MacDonald and Tim Kress-Spatz. In July 2023, Bluesight raised USD 15. 00 mn in a Series C funding round led by Baxter Ventures, marking its sixth funding deal. This investment has allowed Bluesight to focus on expanding its inventory management and spend optimization offerings.
Bluesight provides a suite of solutions tailored for hospital and pharmacy operations, including RFID Medication Management for inventory automation, KitCheck for drug diversion surveillance, ControlCheck for optimizing retail purchasing, and 340B Compliance solutions for effective auditing. Their services also encompass Drug Shortage Management with predictive analytics and Patient Privacy Monitoring to safeguard personal information. Their clientele is primarily healthcare institutions across the US, benefiting from streamlined operations and actionable insights that address the challenges in diverse healthcare environments. Bluesight generates revenue primarily through an annual subscription model for its software solutions.
Key products such as CostCheck and PrivacyPro are included in these subscription packages, focusing on drug spending efficiency and patient privacy enhancement. The company engages in B2B transactions with hospitals and pharmacies, often under multi-year contracts for ongoing support. Their pricing is structured to accommodate various client needs, offering bundled service options for cost savings. Following the recent funding round in July 2023, Bluesight plans to enhance its inventory management and spend optimization capabilities.
The company is set to introduce new products aimed at improving hospital efficiency and anticipates expanding its reach into additional regional markets in the US. The investment will support these initiatives, enabling further development of their product offerings and enhancing their market presence.
Current Investors
Thoma Bravo, Easton Capital Investment Group, New Leaf Venture Partners
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Web Applications, Medical Software, Application Integration Software, Analytics & Performance Software
Website
www.bluesight.com
Verticals
Artificial Intelligence
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Bluesight, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Protenus, Inc. | - | ||||||||
| Add-on | Completed | Sectyr, LLC | - | ||||||||
| Add-on | Completed | Medacist Solutions Group, LLC | - | ||||||||
| Secondary Buyout | Completed | Bluesight, Inc. | - |
Displaying 1 - 4 of 4
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.